Company intelligence / Profile preview

Sydna Farma

Central Jakarta/Gondangdia Menteng, Jakarta, Indonesiasydna-farma.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Sydna Farma is an Indonesian pharmaceutical manufacturer with GMP-certified facilities for solid oral dosage forms, injectables, and secondary packaging. The company has completed at least one clinical bioequivalence study for its contraceptive product Elzsa® compared to Diane® 35. It offers contract manufacturing, product licensing, and is expanding R&D capabilities.

Therapeutic areas: Women's Health
Modalities: Small moleculeHormoneTablet and coated tablet dosage formsInjectable (small volume, non-hormonal)
Industry: Biotech

Drug pipeline

1 asset

fludrocortisone acetate

Commercial

Indications: Addison Disease

Beyond the preview

Go deeper on Sydna Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sydna Farma.

Explore the full profile